TEAM enters the week in a genuinely unusual position: a stock that has nearly doubled in a month, with shorts actively covering, analysts chasing targets higher, and fresh institutional money arriving — yet the day's close was still down 2.8%.
The most striking shift in positioning is the rapid retreat of short sellers. Short interest dropped 26% in a single session on August 25, falling to 7.0% of free float from around 9.9% just weeks earlier. Across the past month, the short position has shrunk by nearly a third. The covering is consistent with a classic post-earnings capitulation: TEAM rallied 31.5% the day after its August 6 results and added another 46.5% over the following five days, forcing out bears who had built exposure when the stock was still trading in the $80s and $90s. Borrowing costs reflect that easing pressure too — cost to borrow has fallen 30% in a week to just 0.30%, well below anything that would indicate fresh short demand. Availability is now above 3,000%, meaning the lending pool is almost entirely unused and there is no structural barrier to new shorts entering — but for now, few are bothering. The put/call ratio nudged up to 0.77 on Tuesday, roughly 1.7 standard deviations above its 20-day average of 0.71. That's a mild hedge rather than a panic, and it fits the picture of investors trimming rather than aggressively fading.
The Street has been busy repricing the stock since earnings, and the direction is almost entirely one way. Across the ten analyst actions filed since August 7, every firm raised its price target — with Morgan Stanley, Wells Fargo, and Truist all moving into the $180s range, Citigroup and Barclays to $170-172, and even hold-rated TD Cowen and UBS lifting targets meaningfully. The freshest action came today from RBC Capital, where Matthew Hedberg initiated with an Outperform and a $215 target — the highest on the Street, implying a further 29% from the current $166.49 close. The consensus mean target is $188.77, leaving roughly 13% implied upside. The bull case rests on Atlassian's FY27 revenue guidance of $7.43 billion — well above prior consensus — combined with expanding AI and automation positioning and a commitment to GAAP profitability. Bears acknowledge the strong print but flag elongated enterprise deal cycles, competitive pressure, subscription-transition friction, and the risk that FY28 growth disappoints after a pull-forward year. The forward earnings multiple has expanded sharply: the P/E has risen roughly 12 points over the past 30 days, and price-to-book is up 6.6 points over the same period — the valuation re-rating is real and the stock now needs to grow into it.
Institutional flows support the bull camp, at least at the margin. AQR Capital roughly quintupled its position to 3.4% of shares in the June quarter, adding over 4.6 million shares. GQG Partners appears to have entered from scratch in the same period, reporting a 3% stake with 7.66 million shares as a new position. BlackRock added 1.2 million shares. The co-founders — Michael Cannon-Brookes and Scott Farquhar — hold a combined 37.4% of shares and neither changed their positions in the March quarter. Against that, CFO James Chuong sold roughly $1.1 million of stock on August 19 across a series of smaller transactions, though at significance scores of 1-2 this looks like routine plan-based selling rather than a signal about the business outlook.
The earnings reaction history is worth keeping in mind. The August 6 print produced a one-day move of +31.5% and a five-day move of nearly +46.5%. The next event is scheduled for October 29. Software peers had a broadly positive week — SPT and APPN each gained around 9%, NOW rose 6.3%, and PATH added 6.9% — making TEAM's own 2.1% weekly gain look relatively subdued given the magnitude of its recent rerating. ASAN and WDAY were closer to flat on the week, suggesting the cohort is not moving in lockstep.
The key tension heading into October is whether the valuation expansion that followed the August print can be justified by the FY27 execution story, or whether the stock consolidates at these levels while the Street waits for evidence that the guidance uplift is sustainable.
See the live data behind this article on ORTEX.
Open TEAM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
